Penny stock hits 10% upper circuit after announcing its Q2 results and dividend

Synopsis: Galaxy Medicare jumped sharply after it reported an H1 FY26 revenue of Rs 18.73 crore (up 9% YoY) and net profit of Rs 2.02 crore (up 18% YoY). Additionally, the business announced an interim dividend of Rs 0.35 per share

The shares of this penny stocks that manufactures and exports of medical devices, POP bandages, and surgical dressings in India are in focus after the company announced its results for the first half of FY26. In this article, we will dive more into the details of it.

With a market capitalisation of Rs 32 crore, the shares of Galaxy Medicare Ltd made a day high of Rs 21.50 per share (upper circuit), up 10 percent from its previous day’s closing price of Rs 19.55 per share. Post listing on the stock exchange in September 2025, the stock has plunged nearly 64 percent.

Q2 Results

Galaxy Medicare’s revenue for H1 FY26 came in at Rs 18.73 crore, up by 9 percent from Rs 17.24 crore in H1 FY25. However, on a sequential basis, revenue declined by 15 percent from Rs 21.96 crore in the second half of FY25. 

Coming to its profitability, the company reported a net profit growth of 18 percent to  Rs 2.02 crore in H1 FY26 as compared to Rs 1.71 crore in H1 FY25. Additionally, on a sequential basis, it recorded a growth of 22 percent from Rs 1.66 crore in the second half of FY25.

On the expenses front, it reported total expenses of Rs 15.87 crore in H1 FY26, which grew by 8 percent as compared to Rs 14.74 crore in H1 FY25. However, on a sequential basis, expenses declined by 20 percent from Rs 19.81 crore in the second half of FY25.

Additionally, the board of directors has declared an interim dividend of Rs 0.35 per share (3.5 percent of face value) for FY26 and has fixed 17th December 2025 as the record date for the dividend, which will be paid within 30 Days from the Date of Declaration.

Founded in 1992, Galaxy Medicare Limited is a prominent manufacturer of surgical and medical equipment.  The business has significant certifications and is renowned for offering cutting-edge, superior solutions.  It uses premium raw materials from reliable suppliers to produce goods like surgical dressings and Plaster of Paris bandages.  Their main goals are to provide dependable goods at reasonable costs and on schedule.

The business employs a knowledgeable staff that keeps up with the most recent advancements in product design and manufacturing methods.  Galaxy Medicare also has a specialised quality control department that inspects each product for design, quality, and finish to uphold high standards.  They are able to produce goods that satisfy global standards because all of their facilities are outfitted with cutting-edge equipment and technology.

Written by Satyajeet Mukherjee

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Penny stock hits 10% upper circuit after announcing its Q2 results and dividend appeared first on Trade Brains.